HOME >> BIOLOGY >> NEWS
OneWorld Health selects Odyssey Research for phase 4 study in India

SAN FRANCISCO, USA / NEW DELHI, INDIA March 28, 2007 -- The Institute for OneWorld Health, a US-based non-profit pharmaceutical company that develops drugs for people with neglected diseases in the developing world, today announced the selection of Odyssey Research, a Bismarck, North Dakota-based clinical trial management organization (TMO) with offices in New Delhi, India, to support its upcoming Phase 4 pharmacovigilance and access study of Paromomycin Intramuscular (IM) Injection for the treatment of visceral leishmaniasis (VL) in India. With approximately 500,000 new cases occurring annually, visceral leishmaniasis, also known as kala-azar or black fever, is the worlds second most deadly parasitic disease following malaria.

"We welcome Odyssey Research as part of our team to further develop Paromomycin IM Injection as a safe, affordable and effective treatment for a major public health problem in India," said Dr. Ahvie Herskowitz, OneWorld Healths Chief Medical Officer. "Odysseys clinical trial management capabilities and depth of experience in India make them a good fit for this important post-approval Phase 4 study."

Odyssey Research will perform regular monitoring of seven clinical sites for the pharmacovigilance module in the Phase 4 study. The study, scheduled to begin later this year, will be conducted in the state of Bihar, India.

The first module will enroll 500 patients in a pharmacovigilance study to confirm the safety and efficacy of Paromomycin IM Injection in an outpatient setting. Over the next three years, up to an additional 1500 patients will be included in two subsequent access modules that will monitor the effectiveness of a progressively extending network of treatment facilities and related logistics systems throughout rural Bihar. The results of the Phase 4 study are intended to provide a model for administering Paromomycin IM Injection safely and effectively in an outpatient setting in remote areas wher
'"/>

Contact: Hal Kane
Hkane@prandcompany.com
415-307-7092
Institute for OneWorld Health
28-Mar-2007


Page: 1 2

Related biology news :

1. Institute for OneWorld Health hosts global health seminar at AAAS Annual Meeting
2. Institute for OneWorld Health awarded $46 million grant to combat diarrheal disease
3. Institute for OneWorld Health hosts panels at ASTMH
4. Institute for OneWorld Health to exhibit at BIO
5. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
6. OneWorld Health awarded Sapling Foundation grant
7. OneWorld Health receives multimillion dollar grant for next steps in control of deadly disease
8. Institute for OneWorld Health CEO speaks at 2005 World Life Sciences Forum, BioVision
9. Institute for OneWorld Health awarded Skoll Foundations Social Entrepreneurship Award
10. OneWorld Health named business leader in public health on 2004 Scientific American 50
11. OneWorld Health presents preliminary clinical trial results at ASTMH

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... PHOENIX (PRWEB) , ... August 03, 2020 , ... ... the company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to ... its clients to strengthen their laboratory supply chain for more than 10 years. ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical stage in ... COVID cure or vaccine, the global economic downturn will only increase price pressures overall ... away and capturing full value from every product launch is critical. However, history shows ...
(Date:7/2/2020)... ... July 02, 2020 , ... Dutch ... the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 ... The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2," ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... PORTLAND, Ore. (PRWEB) , ... August 13, 2020 , ... ... announced the creation of its Scientific Advisory Board (SAB) to research the medical ... medical cannabis can be enhanced when combined with terpenes. The board is focused on ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly ... closed on the purchase of greenfield for a new, expanded manufacturing facility. The ... 21 acres in the initial acquisition, with an option to purchase an additional ...
(Date:7/31/2020)... ... 2020 , ... Diversified Technologies, Inc. has introduced a full ... drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... push-pull configuration; yielding fast fall time for a capacitive load. These all solid-state ...
(Date:7/31/2020)... FRANCISCO (PRWEB) , ... July ... ... provider of cloud-based software for the life sciences industry, today announced the ... presentation platform designed specifically for Medical Science Liaisons (MSLs) and other field ...
Breaking Biology Technology:
Cached News: